259 related articles for article (PubMed ID: 10934161)
1. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
[TBL] [Abstract][Full Text] [Related]
2. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
[TBL] [Abstract][Full Text] [Related]
3. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
Agarwal S; Mathur M; Srivastava A; Ralhan R
Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
[TBL] [Abstract][Full Text] [Related]
4. Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India.
Baral R; Patnaik S; Das BR
Eur J Oral Sci; 1998 Oct; 106(5):907-13. PubMed ID: 9786319
[TBL] [Abstract][Full Text] [Related]
5. MDM2 expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan.
Huang JS; Ho TJ; Chiang CP; Kok SH; Kuo YS; Kuo MY
J Oral Pathol Med; 2001 Jan; 30(1):53-8. PubMed ID: 11140901
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p53 protein overexpression in betel- and tobacco-related oral oncogenesis.
Kaur J; Srivastava A; Ralhan R
Int J Cancer; 1998 Aug; 79(4):370-5. PubMed ID: 9699529
[TBL] [Abstract][Full Text] [Related]
7. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
8. Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population.
Ralhan R; Agarwal S; Nath N; Mathur M; Wasylyk B; Srivastava A
Oral Oncol; 2001 Apr; 37(3):243-50. PubMed ID: 11287278
[TBL] [Abstract][Full Text] [Related]
9. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway.
Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T
Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130
[TBL] [Abstract][Full Text] [Related]
10. mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells.
Bull EK; Chakrabarty S; Brodsky I; Haines DS
Oncogene; 1998 Apr; 16(17):2249-57. PubMed ID: 9619834
[TBL] [Abstract][Full Text] [Related]
11. MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis.
Li XJ; Murai M; Koyama T; Wang DY; Hashimoto K
Jpn J Cancer Res; 2000 May; 91(5):492-8. PubMed ID: 10835493
[TBL] [Abstract][Full Text] [Related]
12. New insights into p53 protein stabilisation in oral squamous cell carcinoma.
Partridge M; Kiguwa S; Emilion G; Pateromichelakis S; A'Hern R; Langdon JD
Oral Oncol; 1999 Jan; 35(1):45-55. PubMed ID: 10211310
[TBL] [Abstract][Full Text] [Related]
13. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein.
Landers JE; Cassel SL; George DL
Cancer Res; 1997 Aug; 57(16):3562-8. PubMed ID: 9270029
[TBL] [Abstract][Full Text] [Related]
14. Low incidence of p53 mutations in betel quid and tobacco chewing-associated oral squamous carcinoma from India.
Kannan K; Munirajan AK; Krishnamurthy J; Bhuvarahamurthy V; Mohanprasad BK; Panishankar KH; Tsuchida N; Shanmugam G
Int J Oncol; 1999 Dec; 15(6):1133-6. PubMed ID: 10568819
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
Kaur J; Srivastava A; Ralhan R
Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
[TBL] [Abstract][Full Text] [Related]
16. Selective compartmentalization of different mdm2 proteins within the nucleus.
Maxwell SA
Anticancer Res; 1994; 14(6B):2541-7. PubMed ID: 7872679
[TBL] [Abstract][Full Text] [Related]
17. p53 and MDM2 expression in oral squamous cell carcinoma.
Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
[TBL] [Abstract][Full Text] [Related]
18. Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index.
Ng IO; Lam KY; Ng M; Regezi JA
Oral Oncol; 1999 Jan; 35(1):63-9. PubMed ID: 10211312
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of Ets-1 overexpression in betel and tobacco related oral cancer.
Pande P; Soni S; Chakravarti N; Mathur M; Shukla NK; Ralhan R
Cancer Detect Prev; 2001; 25(5):496-501. PubMed ID: 11718456
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells.
Gudas JM; Nguyen H; Klein RC; Katayose D; Seth P; Cowan KH
Clin Cancer Res; 1995 Jan; 1(1):71-80. PubMed ID: 9815889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
